A medical device recall compresses timelines while elevating expectations. Contact volumes can surge within hours as patients, caregivers and clinicians all seek clarity. Every response, inbound or outbound, becomes part of the regulatory record.

Delays undermine confidence. Inconsistent messaging creates clinical uncertainty. Documentation gaps invite increased oversight. A single product issue can quickly escalate into a broader question of governance if the response appears unstructured or unstable.

The challenge for manufacturers lies not only in acting quickly, but in executing with accuracy, consistency and control under intense operational and regulatory pressure.

When a leading manufacturer uncovered a defect in a widely distributed device, regulators required immediate public notification, before replacement models or remediation plans were ready.

Contact volumes instantly exceeded internal capacity. Patients, caregivers and clinicians sought urgent guidance, while pharmacies and clinics needed coordinated communication. Every interaction required compliant documentation, intensifying operational pressure. Recognizing the threat, the manufacturer engaged Sedgwick Recall to help stabilize execution, strengthen communication and restore control.

The priority was not merely to scale operations, but to re-establish disciplined, compliant processes that maintained control and confidence across every stakeholder interaction.

The program included:

• Rapid contact center expansion: Within 48 hours, Sedgwick scaled from 50 to 400 agents to triage inquiries, provide clear guidance and manage replacement vouchers.
• A comprehensive digital voucher platform: A custom-built application streamlined voucher allocation and device replacements, accelerating agent readiness and ensuring consistent, auditable case handling.
• Coordinated point‑of‑care engagement: Sedgwick alerted more than 70,000 pharmacies, clinics and hospitals, enabling direct outreach to affected consumers.
• Return kit fulfillment and secure disposition: Return kits enabled compliant device collection, while secure quarantine protected chain‑of‑custody and prevented affected devices from re‑entering circulation.

Over the course of the recall, Sedgwick delivered measurable, business‑critical results:

• Restored call center performance: Within days, average hold times dropped from over an hour to minutes, reinforcing patient and clinician confidence.
• Accelerated product replacement: Streamlined distribution through local points of care ensured affected consumers received replacements quickly, reducing disruption and strengthening brand credibility.
• Ensured secure and compliant device recovery: Returned devices were quarantined, tracked and processed in full regulatory alignment, eliminating residual market risk and safeguarding chain-of-custody.
• Strengthened regulatory readiness and audit assurance: Comprehensive documentation, traceability, and reporting protocols supported regulatory oversight and positioned the manufacturer to demonstrate full compliance.

This is what effective recall surge support looks like when it is engineered for control, compliance and brand protection, not just volume absorption.